Candriam Equities L Oncology, N - Capitalisation

WKN A3D92J | ISIN LU2346866317 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 IE00B613WX69 Janus Henderson Global Life Sciences Fund Z2 USD +42,47 % +15,75 % 2,54
2 IE000G3N3NE7 Janus Henderson Global Life Sciences Fund G2 EUR +40,43 % +15,39 % 2,46
3 IE00BFRSYJ83 Janus Henderson Global Life Sciences Fund H2 USD +41,24 % +15,75 % 2,46
4 IE000RUGMMJ8 Janus Henderson Global Life Sciences Fund G2 USD +41,24 % +15,81 % 2,45
5 IE00BRJG6X20 Janus Henderson Global Life Sciences Fund I2 EUR +39,34 % +15,33 % 2,40
17 LU2346866317 Candriam Equities L Oncology, N - Capitalisation +37,72 % +16,13 % 2,18
339 LU1769944791 Variopartner SICAV - MIV Global Medtech Fund N1 CHF -14,53 % +17,26 % -0,99
340 LU1769944874 Variopartner SICAV - MIV Global Medtech Fund N2 EUR -14,11 % +16,83 % -0,99
341 LU0329630999 Variopartner SICAV - MIV Global Medtech Fund P1 CHF -14,87 % +17,26 % -1,01
342 LU0329630130 Variopartner SICAV - MIV Global Medtech Fund P2 EUR -14,46 % +16,83 % -1,01
343 LU0580237955 Bellevue Funds (Lux) - Bellevue Medtech & Services HB CHF - Accumulating -14,13 % +16,33 % -1,02